Sedation of Advanced Endoscopic Procedure

Status Completed

Clinical Trial Summary

To evaluate the impacts of target-control infusion (TCI) and bispectral index (BIS) monitoring during advanced endoscopic procedure.

Clinical Trial Description

Anesthesia requirements for advanced endoscopic procedures are approaching those of specialized surgical interventions. Although many other sedative agents are used prior to and during endoscopy, none approach propofol in terms of desirable properties. The risk of propofol sedation for interventional procedures such as endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), and therapeutic endoscopy are among the highest for any sedated endoscopic procedure. The reasons are many: the intensity of stimulation encountered during these procedures is similar to many minor surgeries; the airway management is complex and requires constant attention; the incidence of hypoxemia is high, and the time available for recognition and management is limited. In order to reap the benefits of advanced endoscopic procedures, anesthesiologists must rise to the challenge. This requires a dedicated anesthetic team practicing safe, efficient, and effective sedation techniques for advanced endoscopic procedures. Ongoing research into novel infusion methods can add safety to the existing sedation techniques and address some of the concerns related to sedative quality. This is a randomized controlled and prospective study. To evaluate the benefits when we use target-controlled infusion of propofol (TCI) with/without bispectral index monitoring in patients undergoing advanced endoscopic procedure. The primary outcome is the total amount of propofol. The secondary outcomes are patients' and endoscopists' satisfaction, sedative-related adverse events, recovery time. ;

Study Design

Related Conditions & MeSH terms

Sedation

Clinical Trial Details

NCT number	NCT03172078
Study type	Interventional
Source	National Taiwan University Hospital
Contact
Status	Completed
Phase	N/A
Start date	June 5, 2017
Completion date	August 22, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03399019` - Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia	N/A
Completed	`NCT03220880` - Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
Recruiting	`NCT04820205` - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children	N/A
Recruiting	`NCT04549623` - End-Tidal Carbon Dioxide Monitoring Device for Sedation During Endoscopic Ultrasonography	N/A
Recruiting	`NCT04822064` - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation	N/A
Completed	`NCT01001533` - Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation	N/A
Completed	`NCT01527903` - A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit	Phase 4
Completed	`NCT00747721` - Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU	Phase 1
Completed	`NCT00158873` - Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects	Phase 4
Terminated	`NCT00205517` - Sedation and Psychopharmacology in Critical Care	N/A
Recruiting	`NCT04096768` - The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation	Phase 3
Active, not recruiting	`NCT05082623` - The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters	N/A
Suspended	`NCT03285165` - Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients	Phase 2/Phase 3
Active, not recruiting	`NCT04788589` - Sedation and Ventilator Weaning Protocol in PICU	N/A
Completed	`NCT03425474` - Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy	Phase 3
Recruiting	`NCT06061159` - The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction	Phase 4
Completed	`NCT06449365` - Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy	Phase 4
Completed	`NCT02171910` - Doxapram as an Additive to Propofol Sedation in Sedation for ERCP	Phase 4
Completed	`NCT02211118` - Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD	Phase 4
Completed	`NCT01694745` - EUROpean Pain Audit In Neonates	N/A